Coadministration With Lopinavir and Ritonavir Decreases Exposure to BILR 355, a Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy Volunteers
Year: 2010
Type: article
Study design: Clinical Trial
Authors: Fenglei Huang, Paul Scholl, David B. Huang, Thomas R. MacGregor, Richard Vinisko, Mark A. Castles, Frank Berger, Patrick Robinson
Institution: Boehringer Ingelheim (United States)
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2032208061
